About the journal
The leading peer-reviewed journal on multiple sclerosis — pathogenesis, disease-modifying therapy, neurorehabilitation, and outcomes research. Founded under Edward Arnold in 1995 and transferred to SAGE in 2006, where it continues as Multiple Sclerosis Journal.
Scope
- MS pathogenesis and neuroimmunology
- disease-modifying therapies
- neurorehabilitation in MS
- MS epidemiology and outcomes
Editorial contributors
- Alan J. Thompson
Editor-in-Chief (from 2006)
- Dame Ingrid V. Allen
Founding Editor-in-Chief (1995–2000)